Akero Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here. And it's my pleasure to introduce Andrew Cheng, CEO of Akero Therapeutics. Just as a quick reminder, the format for today is a fireside chat. But before we get into Q&A, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.
If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, Andrew, thanks for joining us today, and I thought maybe we could kick it off with just some introductory comments and then we can get into the Q&A.
Sure. So first of all, thank you for having me today, Mike, and it's my
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |